Hanna Piotrowska-kempisty - Toxicology

Author Information

Hanna Piotrowska-Kempisty is affiliated with the Department of Toxicology at the Poznan University of Medical Sciences, located at Dojazd 30 St., PL-60-631 Poznan, Poland. Her work is highly regarded in the field of toxicology, with a significant focus on exploring novel carriers for pharmaceutical compounds and investigating signaling pathways in cellular processes.

Research Contributions

Hanna Piotrowska-Kempisty has made substantial contributions to the field of toxicology and related biomedical sciences. Her research encompasses a diverse range of topics, including the development of non-toxic carriers for drug delivery, enhancement of drug solubility, and the study of cellular permeability. Additionally, she has explored gene ontology and signaling pathways related to cell differentiation and immune processes. Her work also extends to understanding the modulation of cancer pathways and the characterization of stem cells from perinatal tissues.

Aliases

Hanna Piotrowska-Kempisty is also known by the aliases H Piotrowska-kempisty and H. Piotrowska-Kempisty in various publications and citations.

Publication and Citation Metrics

Metric	Value
Total Papers Published	77
Total Citation Count	778
H-index	15

Publications:

APTES-Modified SBA-15 as a Non-Toxic Carrier for Phenylbutazone

DOI: 10.3390/ma15030946

Year: 2022

Improved solubility of lornoxicam by inclusion into SBA-15: comparison of loading methods.

DOI: 10.1016/j.ejps.2022.106133

Year: 2022

Permeability of the Perindopril Arginine under In Vitro Conditions across Caco-2 Monolayer and Biomimetic Phospholipid Membrane

DOI: 10.3390/molecules27072232

Year: 2022

Gene Ontology Groups and Signaling Pathways Regulating the Process of Avian Satellite Cell Differentiation

DOI: 10.3390/genes13020242

Year: 2022

Transcriptomic Profile of New Gene Markers Encoding Proteins Responsible for Structure of Porcine Ovarian Granulosa Cells

DOI: 10.3390/biology10111214

Year: 2021

Mesenchymal Stem/Stromal Cells Derived from Human and Animal Perinatal Tissues—Origins, Characteristics, Signaling Pathways, and Clinical Trials

DOI: 10.3390/cells10123278

Year: 2021

Attenuation of Pancreatic Cancer In Vitro and In Vivo via Modulation of Nrf2 and NF-κB Signaling Pathways by Natural Compounds

DOI: 10.3390/cells10123556

Year: 2021

Expression Profile of New Gene Markers and Signaling Pathways Involved in Immunological Processes in Human Cumulus-Oophorus Cells

DOI: 10.3390/genes12091369

Year: 2021

Insight into theranostic nanovesicles prepared by thin lipid hydration and microfluidic method.

DOI: 10.1016/j.colsurfb.2021.111871

Year: 2021

Cellular Processes in Human Ovarian Follicles Are Regulated by Expression Profile of New Gene Markers—Clinical Approach

DOI: 10.3390/jcm11010073

Year: 2021

How Does ECETOC TRA Work?

How Can Toxic Releases Be Mitigated?

What is the Future of Chronopharmacology in Toxicology?

How Does Individual Susceptibility Affect Exposure Dose?

How are Neutrons Relevant to Toxicology?

What Makes the Fetus Susceptible to Toxins?

What Are the Treatment Options for Cyanide Poisoning?

Can the Placental Barrier Be Compromised?

How Can Toxins Cause Hyperglycemia?

Why is Proper Labeling and Packaging Crucial?

Partnered Content Networks

Relevant Topics